Trial record 1 of 1 for: A phase II trial of sequential SGN35 therapy with Adriamycin, vinblastine, and dacarbazine (S-AVD) for older patients with untreated Hodgkin lymphoma
Previous Study | Return to List | Next Study
Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma
This study is ongoing, but not recruiting participants.
Robert H. Lurie Cancer Center
Seattle Genetics, Inc.
Information provided by (Responsible Party):
First received: October 18, 2011
Last updated: September 27, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Estimated Study Completion Date:||May 2018|
|Estimated Primary Completion Date:||May 2017 (Final data collection date for primary outcome measure)|